# Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

> **NCT01016002** · PHASE2 · UNKNOWN · sponsor: **University of Salzburg** · enrollment: 35 (estimated)

## Conditions studied

- Non-curative Resectable Bile Duct Carcinoma

## Interventions

- **DRUG:** Temoporfin

## Key facts

- **NCT ID:** NCT01016002
- **Lead sponsor:** University of Salzburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2009-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016002, "Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01016002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*